IP Library Granted Patent US 9,427,295
Granted Patent B2
US 9,427,295 · App. 14/512,228 · Granted Aug 30, 2016

Method of removing an inflated implant from a bladder

Inventors: Kevin G. Connors (Wellesley, MA); William L. Pintauro (Ft. Lauderdale, FL); Sheila K. Wallin (Carlsbad, CA); Hung H. Cao (Corona, CA)
A61F2/004A61B1/307A61B5/205A61B5/6852A61B5/72A61F2/0027A61F2/06A61M25/10A61F2/042A61F2002/068A61M25/1002A61M2025/0076A61M2210/1078A61M2210/1085
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,427,295
App. No.
14/512,228
Granted
Aug 30, 2016
Kind
B2
Abstract

An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. Removal can be accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways.

Claims (15)

1. A method of removing an inflated implant from a urinary bladder, the inflated implant having been previously implanted within the urinary bladder, the method comprising:

locating with direct visualization an implant within a urinary bladder, the implant being in an inflated condition;

capturing the implant within the urinary bladder with a removal device after visualization, and then:

compromising at least a portion of the implant such that an inflation substance within the implant can escape by dissolving a material of the inflated implant in situ;

removing the inflation substance out of the implant; and

removing the implant from the urinary bladder with the removal device.

2. The method of claim 1 , wherein dissolving the material comprises dissolving at least a portion of one of a wall, a seam and a valve.

3. The method of claim 1 , wherein dissolving the material comprises catalyzing or accelerating dissolution by an accelerating event within the urinary bladder consisting of at least one of changing pH, introducing an initiator or accelerator, and reducing pressure.

4. The method of claim 1 , wherein removing the inflation substance out of the implant comprises deflating the implant by compressing the implant.

5. The method of claim 1 , further comprising advancing the removal device transurethrally into the urinary bladder.

6. The method of claim 1 , wherein locating with direct visualization comprises locating the inflated implant floating within the urinary bladder.

7. The method of claim 1 , wherein locating with direct visualization comprises locating the inflated implant within the urinary bladder with a urological cystoscope.

8. The method of claim 1 , wherein removing the implant from the urinary bladder further comprises removing the implant thru the urethra.

9. The method of claim 1 , wherein capturing the inflated implant comprises surrounding the inflated implant with a retrieval loop of the removal device and tightening the retrieval loop around the inflated implant.

10. The method of claim 9 , further comprising advancing the retrieval loop out from within a tubular body of the removal device to thereby enlarge the retrieval loop prior to capturing the inflated implant.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2019
From: ATTENUEX TECHNOLOGIES, INC.
To: SOLACE THERAPEUTICS, INC.
Reel/Frame 049282/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2017
From: SOLACE THERAPEUTICS, INC.
To: ATTENUEX TECHNOLOGIES, INC.
Reel/Frame 041113/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2017
From: CONNORS, KEVIN G.; PINTAURO, WILLIAM L.; WALLIN, SHEILA K.; KILCOYNE, JOHN T.; CAO, HUNG H.; NGUYEN, KHOI M.; YUREK, MATTHEW T.
To: SOLACE THERAPEUTICS, INC.
Reel/Frame 041113/0489 →
Continuity (8)
Continuation 13660814 · Oct 25, 2012
Continuation 12343120 · Dec 23, 2008
Division 10391448 · Mar 17, 2003
Continuation 10391446 · Mar 17, 2003
Continuation In Part 09723309 · Nov 27, 2000
Provisional Application 60415949 · Oct 3, 2002
Provisional Application 60197095 · Apr 14, 2000
Related Publication 20150148588A1 · May 28, 2015